Not logged in.png)
Share.png)
SaveShare Save Phase I study of oral metronomic gemcitabine (D07001) in patients with advanced solid tumors
Chiang, Nai-Jung; Lee, Jih-Hsiang; Chen, Ming-Huang; Chao, Yee; Su, Wu-Chou; Bai, Li-Yuan; Wu, Shang-Yin; Hsu, Chih-Hung; Shan, Yan-Shen; Li, Chung-Pin; Chen, Shang-Hung; Chung, Wei-Pang; Hao, Wei-Hua; Chen, Li-Tzong; Lin, Chia-Chi Share Save Share Save Share Save Hepatic Events During Immune Checkpoint Inhibitor Treatment Between Liver and Non-Liver Malignancies in Hepatitis B Endemic AreasHung, Yi-Ping; Lee, Pei-Chang; Chang, Yen-Hwa; Yang, Muh-Hwa; Chiu, Chao-Hua; Chen, Ming-Huang; Lan, Keng-Hsin; Lee, I-Cheng; Hou, Ming-Chih; Chao, Yee; Huang, Yi-Hsiang Share Save Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trialQiu, Miao-Zhen; Oh, Do-Youn; Kato, Ken; Arkenau, Tobias; Tabernero, Josep; Correa, Marcia Cruz; Zimina, Anastasia, V; Bai, Yuxian; Shi, Jianhua; Lee, Keun-Wook; Wang, Jufeng; Poddubskaya, Elena; Pan, Hongming; Rha, Sun Young; Zhang, Ruixing; Hirano, Hidekazu; Spigel, David; Yamaguchi, Kensei; Chao, Yee; Wyrwicz, Lucjan; Disel, Umut; Cid, Roberto Pazo; Fornaro, Lorenzo; Evesque, Ludovic; Wang, Hongwei; Xu, Yaling; Li, Jiang; Sheng, Tao; Yang, Silu; Li, Liyun; Moehler, Markus; Xu, Rui-Hua Share Save Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium-90 resin microspheres in Taiwan: data from the RESIN registryLee, Rheun-Chuan; Liang, Po-Chin; Liang, Huei-Lung; Chen, Yung-Fang; Yu, Chun-Yen; Cheng, Pin-Nan; Hung, Chien-Fu; Hsia, Cheng-Yuan; Lai, Hsueh-Chou; Ho, Ming-Chih; Cheng, Yu-Fan; Liu, Yi-Sheng; Chao, Yee; Chen, Chien-Hung Share Save A hierarchical fusion strategy of deep learning networks for detection and segmentation of hepatocellular carcinoma from computed tomography imagesLee, I-Cheng; Tsai, Yung-Ping; Lin, Yen-Cheng; Chen, Ting-Chun; Yen, Chia-Heng; Chiu, Nai-Chi; Hwang, Hsuen-En; Liu, Chien-An; Huang, Jia-Guan; Lee, Rheun-Chuan; Chao, Yee; Ho, Shinn-Ying; Huang, Yi-Hsiang Share Save Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trialKang, Yoon-Koo; Ryu, Min-Hee; Di Bartolomeo, Maria; Chau, Ian; Yoon, Harry; Kim, Jong Gwang; Lee, Keun-Wook; Oh, Sang Chul; Takashima, Atsuo; Kryzhanivska, Anna; Chao, Yee; Evesque, Ludovic; Schenker, Michael; Mcginn, Arlo; Zhao, Yufan; Lee, Jennifer; Wyrwicz, Lucjan; Boku, Narikazu Share Save Share Save Prevalence of claudin-18 isoform 2 (CLDN18.2) positivity in locally advanced (LA) unresectable or metastatic gastric or gastroesophageal junction (mg/GEJ) adenocarcinoma in patients (pts) in the Asia region: Phase III SPOTLIGHT and GLOW studiesBang, Y-J.; Shen, L.; Kang, Y-K.; Chao, Y.; Soo, H. H. F.; Sunpaweravong, P.; Moran, D.; Guerrero, A.; Li, R.; Pavese, J.; Matsangou, M.; Bhattacharya, P.; Shitara, K.; Xu, R-H. Share Save Prevention of metastasis formation by combination therapy targeting Her2 and PD-L1 in Her2-expressing tumors based on observed efficacious vaccination against Her2-positive tumorsTobias, J.; Hoegler, S.; Kundi, M.; Lin, D. Shih-Cheih; Chao, Y.; Garner-Spitzer, E.; Ede, N.; Zielinski, C.; Good, A.; Wiedermann, U. Share Save Zanidatamab (zani) plus chemotherapy (chemo) and tislelizumab (tis) as first-line (1l) therapy for patients (pts) with advanced HER2-positive (+) gastric/gastroesophageal junction adenocarcinoma (GC/GEJC): Updated results from a phase Ib/II studyLee, K-W.; Bai, L-Y.; Jung, M.; Ying, J.; Im, Y-H.; Oh, D-Y.; Cho, J. Y.; Oh, S. C.; Chao, Y.; Zhou, P.; Bao, Y.; Kang, Y-K. Share Save PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular CarcinomaAbou-Alfa, Ghassan K.; Galle, Peter R.; Chao, Yee; Erinjeri, Joseph; Heo, Jeong; Borad, Mitesh J.; Luca, Angelo; Burke, James; Pelusio, Adina; Agathon, Delphine; Lusky, Monika; Breitbach, Caroline; Qin, Shukui; Gane, Edward Share Save Anti-VEGF Therapy Possibly Extends Survival in Patients With Colorectal Brain Metastasis by Protecting Patients From Neurologic DisabilityChen, Chih-Wen; Ou, Tao-Shen; Chen, Wei-Shone; Jiang, Jeng-Kai; Yang, Shung-Haur; Wang, Huann-Sheng; Chang, Shih-Ching; Lan, Yuan-Tzu; Lin, Chun-Chi; Lin, Hung-Hsin; Huang, Sheng-Chieh; Cheng, Hou-Hsuan; Yang, Yi-Wen; Lin, Yu-Zu; Chao, Yee; Wang, Ling-Wei; Teng, Hao-Wei Share Save Radiologic Patterns Determine the Outcomes of Initial and Subsequent Transarterial Chemoembolization in Intermediate-Stage Hepatocellular CarcinomaHung, Ya-Wen; Lee, I-Cheng; Chi, Chen-Ta; Lee, Rheun-Chuan; Liu, Chien-An; Chiu, Nai-Chi; Hwang, Hsuen-En; Chao, Yee; Hou, Ming-Chih; Huang, Yi-Hsiang Share Save Elevated PD-L1 Expression and Microsatellite Instability in Elderly Patients With Gastric CancerChen, Tien-Hua; Chen, Ming-Huang; Hung, Yi-Ping; Chiang, Nai-Jung; Huang, Kuo-Hung; Lin, Yi-Hsiang; Lin, Ryan Weihsiang; Chao, Yee; Li, Anna Fen-Yau; Yu, Hung-Yuan; Hwang, Hsuen-En; Yeh, Yi-Chen; Wang, Yu-Chao; Fang, Wen-Liang Share Save Pembrolizumab as Second-Line Therapy for Advanced Hepatocellular Carcinoma: Longer-Term Follow-Up From the Phase 3 KEYNOTE-240 TrialMerle, Philippe; Kudo, Masatoshi; Edeline, Julien; Bouattour, Mohamed; Cheng, Ann-Lii; Chan, Stephen Lam; Yau, Thomas; Garrido, Marcelo; Knox, Jennifer; Daniele, Bruno; Breder, Valeriy; Lim, Ho Yeong; Ogasawara, Sadahisa; Cattan, Stephane; Chao, Yee; Siegel, Abby B.; Martinez-Forero, Ivan; Wei, Ziwen; Liu, Chih-Chin; Finn, Richard S. Share Save Artificial intelligence-based immunoprofiling serves as a potentially predictive biomarker of nivolumab treatment for advanced hepatocellular carcinomaLee, Jan-Mou; Hung, Yi-Ping; Chou, Kai-Yuan; Lee, Cheng-Yun; Lin, Shian-Ren; Tsai, Ya-Han; Lai, Wan-Yu; Shao, Yu-Yun; Hsu, Chiun; Hsu, Chih-Hung; Chao, Yee Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
